Corynebacterium urealyticum is a well-known opportunistic uropathogen that can occur with cystitis, pyelonephritis, and urinary sepsis. Although a wide variety of coryneform bacteria have been found from the male genital tract of prostatitis patients, only one clinical case of prostatitis caused by C. urealyticum has been reported. The aim of this study was to evaluate the in vitro tropism of C. urealyticum towards LNCaP (lymph node carcinoma of the prostate) human cells line and the influence of acetohydroxamic acid as an irreversible urease inhibitor on different aspects of its pathogenicity by means of several in vitro tests, such as the determination and analysis of growth curves, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, the production of biofilms, and adhesion to LNCaP and HeLa cell lines. Results have brought new pieces of evidence on the in vitro tropism of C. urealyticum for the human prostate cell line LNCaP and the therapeutic use of the irreversible urease inhibitors such as acetohydroxamic acid (AHA), not only as enzyme blockers to facilitate the removal of encrustations but also as modulators of some pathogenic mechanisms. These interesting preliminary data allow us to assert that there is a real possibility that C. urealyticum is a new candidate for chronic idiopathic prostatitis.
Microorganisms. 2020 Mar 25*** epublish ***
Daria Nicolosi, Carlo Genovese, Marco Alfio Cutuli, Floriana D'Angeli, Laura Pietrangelo, Sergio Davinelli, Giulio Petronio Petronio, Roberto Di Marco
Department of Biomedical and Biotechnological Sciences-Microbiology Section, Università degli Studi di Catania, 95100 Catania, Italy., Department of Medicine and Health Sciences "Vincenzo Tiberio", Università degli Studi del Molise-III Ed Polifunzionale, 86100 Campobasso, Italy.